Even as Wegovy, Mounjaro, and other GLP-1 therapies become household names on par with Tylenol and Kleenex, financially burdened payers and employers are beginning to restrict coverage and drop the drugs from their formularies
A study by Johnston et al 24 indicated that vitamin C supplementation (500mg/day) maintains reduced glutathione concentrations in the blood and improves the overall antioxidant protection capacity of the blood
On 15 November 2023, a spokesperson for NICE told The Pharmaceutical Journal : The patient population for this trial falls outside of the remit for our appraisal of semaglutide for managing overweight and obesity
Insurance coverage for GLP-1 medications like Ozempic has become increasingly restrictive, with most major carriers including Aetna limiting approval to patients with diagnosed type 2 diabetes rather than obesity alone
It requires prompt medical attention and can range from mild, self-limiting episodes to severe, life-threatening complications